Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +0.58% | +4.19% | +8.75% |
03-28 | Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Evolution of the average Target Price on Reneo Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Reneo Pharmaceuticals, Inc.
Ladenburg Thalmann | |
HC Wainwright | |
Piper Sandler | |
Baird | |
William Blair & Co. | |
BofA Securities | |
SVB Leerink | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- RPHM Stock
- Consensus Reneo Pharmaceuticals, Inc.